TCL Archive LabCorp Marketing Of Ovarian Cancer Test Unlawful, FDA Says In Warning Letter. October 17, 2008
TCL Archive ODAC Nixes Abraxane for Adjuvant Breast Cancer, While Genasense Falls Victim to Its Randomized Trial. September 8, 2006
TCL Archive Burton’s Clinic Reopens; Some Insurers Reportedly Reimbursing; New York Congressman Calls For Evaluation March 28, 1986
TCL Archive In Brief: ONS Forms Six New Special Interest Groups; Four Named To Michigan Breast Cancer Center April 13, 1990
TCL Archive In Brief: NCI Ponders How Extra $40 Million Will Be Spent, Will Submit Plans to NCAB At Upcoming Meeting January 14, 1983
